SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-12-062275
Filing Date
2012-09-07
Accepted
2012-09-07 16:15:34
Documents
5
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A a12-18654_110qa.htm 10-Q/A 71993
2 EX-10.1 a12-18654_1ex10d1.htm EX-10.1 479046
3 EX-31.3 a12-18654_1ex31d3.htm EX-31.3 4974
4 EX-31.4 a12-18654_1ex31d4.htm EX-31.4 4833
5 GRAPHIC g186541kc13i001.gif GRAPHIC 1375
  Complete submission text file 0001104659-12-062275.txt   563785
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-19319 | Film No.: 121080224
SIC: 2834 Pharmaceutical Preparations